MGRX (Mangoceuticals) Common Stock: $0.00 Mil (As of Mar. 2026)


MGRX Mangoceuticals Inc MGRX
26 GF Score
Price $0.37
GF Value $0.32
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Mangoceuticals Common Stock?

Mangoceuticals MGRX -1.46% 26 Common Stock is $0.00 Mil as of Mar. 2026. GuruFocus rates MGRX with a GF Score™ of 26/100 and a GF Value™ of $0.32 (Modestly Overvalued). The stock has 2 warning signs investors should review.

Mangoceuticals's quarterly common stock increased from Sep. 2025 ($0.00 Mil) to Dec. 2025 ($0.00 Mil) but then stayed the same from Dec. 2025 ($0.00 Mil) to Mar. 2026 ($0.00 Mil).

Mangoceuticals's annual common stock stayed the same from Dec. 2023 ($0.00 Mil) to Dec. 2024 ($0.00 Mil) but then increased from Dec. 2024 ($0.00 Mil) to Dec. 2025 ($0.00 Mil).

Mangoceuticals Common Stock Historical Data

* Premium members only.

The historical data trend for Mangoceuticals's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mangoceuticals Common Stock Chart

Mangoceuticals Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
0.00 0.00 0.00 0.00 0.00

Mangoceuticals Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
MGRX
26GF Score
Mangoceuticals Inc MGRX
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mangoceuticals Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.00 Mil mean?
Mangoceuticals (MGRX) has a Common Stock of $0.00 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Mangoceuticals and its competitors.
Is Mangoceuticals' Common Stock too high?
Mangoceuticals' current Common Stock is $0.00 Mil. Overall, Mangoceuticals has a GF Score™ of 26/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Mangoceuticals' Common Stock compare to WLSS and ACON?
Mangoceuticals' Common Stock of $0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Healthcare Providers & Services company?
A good Common Stock depends on the Healthcare Providers & Services industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Mangoceuticals and its competitors. Mangoceuticals's current Common Stock is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mangoceuticals stock overvalued right now?
Based on GuruFocus' analysis, Mangoceuticals (MGRX) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.32, compared to a current price of $0.37 — trading 14.1% above its estimated fair value. The current Common Stock is $0.00 Mil. Mangoceuticals' overall GF Score™ is 26/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Mangoceuticals (MGRX), the current Common Stock is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mangoceuticals (MGRX) Overvalued in 2026?

Based on GuruFocus' analysis, Mangoceuticals stock appears to be overvalued. The current stock price of $0.37 is trading 14.1% above its estimated GF Value™ of $0.32. GuruFocus considers Mangoceuticals to be Modestly Overvalued.

Key valuation signals for MGRX:

  • Common Stock: $0.00 Mil
  • GF Value™: $0.32 vs. price of $0.37 (14.1% above fair value)
  • GF Score™: 26/100 with 2 warning signs

No single metric tells the full story. See the MGRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mangoceuticals Business Description

Address 17130 Dallas Parkway, Suite 240, Dallas, TX, USA, 75248
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
26GF Score

Get the complete analysis for MGRX

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.37
Price
$0.32
GF Value